Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

779
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
779
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

906
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
906
Glaucoma: Overview01:25

Glaucoma: Overview

1.0K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.0K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

69
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rates, Timing, and Predictors of Retreatment Across Risk-Cohorts in Retinopathy of Prematurity: Intravitreal Bevacizumab Injection vs Laser.

American journal of ophthalmology·2026
Same author

Genetic Testing in Inherited Retinal Disease: Current Strategies and Future Directions.

Journal of personalized medicine·2026
Same author

Trends in the Initial Treatment for Retinopathy of Prematurity in the United States.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

Bilateral Opposing Lens Dislocation and Retinal Detachment in LTBP2-Associated Weill-Marchesani Syndrome: Surgical Sequencing and Multidisciplinary Pediatric Management.

Retinal cases & brief reports·2026
Same author

Minimizing Risk in Scleral Buckle Surgery: A Novel Approach to Belt Loop Creation Using a Guarded Diamond Blade.

Retinal cases & brief reports·2026
Same author

Multi-grader validation of the telemedicine retinopathy of prematurity severity score.

Scientific reports·2026

Related Experiment Video

Updated: Nov 2, 2025

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.1K

Pharmacotherapy as an adjunct to vitrectomy.

Victor M Villegas1, Mónica P González2, Audina M Berrocal3

  • 1Department of Ophthalmology, University of Puerto Rico, San Juan, PR, USA; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.

Therapeutic Advances in Ophthalmology
|June 9, 2021
PubMed
Summary
This summary is machine-generated.

Pharmacotherapy enhances outcomes in vitreoretinal surgery. Medications like triamcinolone acetonide and dexamethasone are effective adjuncts to vitrectomy for common eye conditions.

Keywords:
adjunctdiabetic retinopathyepiretinal membranepharmacotherapyproliferative vitreoretinopathyvitrectomy

More Related Videos

A Step by Step Protocol for Subretinal Surgery in Rabbits
12:31

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

15.7K
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.0K

Related Experiment Videos

Last Updated: Nov 2, 2025

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.1K
A Step by Step Protocol for Subretinal Surgery in Rabbits
12:31

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

15.7K
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.0K

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Pharmacology

Background:

  • Vitreoretinal surgery has significantly evolved.
  • Intravitreal pharmacotherapy offers new avenues to improve surgical results.

Purpose of the Study:

  • To review evidence for pharmacotherapies as adjuncts to vitrectomy.
  • To discuss common etiologies where these treatments are beneficial.

Main Methods:

  • Review of supporting evidence for various pharmacotherapies.
  • Focus on drugs like triamcinolone acetonide, dexamethasone, and angiogenesis inhibitors.

Main Results:

  • Corticosteroids (triamcinolone acetonide, dexamethasone) and anti-VEGF agents show proven efficacy and safety.
  • Other pharmaceuticals demonstrate promising results in preliminary studies.

Conclusions:

  • Individualized pharmacotherapy before, during, and after vitrectomy is increasingly adopted.
  • Growing evidence supports pharmacotherapy as a valuable adjunct to vitreoretinal surgery.